EvlaBio ^None

EvlaBio is a biotech company that develops drug programs to treat medical conditions that are currently not being addressed. They have two antibody programs in their pipeline, one for hepatocellular carcinoma and another for chronic kidney disease with left ventricular hypertrophy. The former is ready for Phase 1 while the latter is still in the pre-clinical stage.